%0 Journal Article
%T WTAP and m6A-modified circRNAs modulation during stress response in acute myeloid leukemia progenitor cells.
%A Iaiza A
%A Mazzanti G
%A Goeman F
%A Cesaro B
%A Cortile C
%A Corleone G
%A Tito C
%A Liccardo F
%A De Angelis L
%A Petrozza V
%A Masciarelli S
%A Blandino G
%A Fanciulli M
%A Fatica A
%A Fontemaggi G
%A Fazi F
%J Cell Mol Life Sci
%V 81
%N 1
%D 2024 Jun 23
%M 38909325
%F 9.207
%R 10.1007/s00018-024-05299-9
%X N6-methyladenosine (m6A) is one of the most prevalent and conserved RNA modifications. It controls several biological processes, including the biogenesis and function of circular RNAs (circRNAs), which are a class of covalently closed-single stranded RNAs. Several studies have revealed that proteotoxic stress response induction could be a relevant anticancer therapy in Acute Myeloid Leukemia (AML). Furthermore, a strong molecular interaction between the m6A mRNA modification factors and the suppression of the proteotoxic stress response has emerged. Since the proteasome inhibition leading to the imbalance in protein homeostasis is strictly linked to the stress response induction, we investigated the role of Bortezomib (Btz) on m6A regulation and in particular its impact on the modulation of m6A-modified circRNAs expression. Here, we show that treating AML cells with Btz downregulated the expression of the m6A regulator WTAP at translational level, mainly because of increased oxidative stress. Indeed, Btz treatment promoted oxidative stress, with ROS generation and HMOX-1 activation and administration of the reducing agent N-acetylcysteine restored WTAP expression. Additionally, we identified m6A-modified circRNAs modulated by Btz treatment, including circHIPK3, which is implicated in protein folding and oxidative stress regulation. These results highlight the intricate molecular networks involved in oxidative and ER stress induction in AML cells following proteotoxic stress response, laying the groundwork for future therapeutic strategies targeting these pathways.